TMS Therapy in Australia: How It Works, Medicare and the Evidence

An open spiral notebook and pen on a wooden shelf beside a green pot plant and a cup

If antidepressants haven’t helped your depression, you may have heard about TMS, short for transcranial magnetic stimulation. It’s a medical treatment that uses magnetic pulses to stimulate the parts of the brain involved in mood. In Australia it’s prescribed by psychiatrists, and Medicare has funded it for some adults with depression since 1 November 2021 (Department of Health and Aged Care [DoHAC], n.d.-b).

This guide explains what TMS is, what the research says, who can get it through Medicare and how psychology fits alongside it. The Talk Shop doesn’t provide TMS; this is general information to help you talk it through with your doctor.

The short answer: TMS (usually given as repetitive TMS, or rTMS) is a non-invasive treatment for depression. A coil on your head sends magnetic pulses to the brain while you’re awake (Royal Australian and New Zealand College of Psychiatrists [RANZCP], 2018). Medicare funds a first course for adults with a major depressive episode that hasn’t improved after adequate trials of at least two classes of antidepressants, unless contraindicated, when an rTMS-trained psychiatrist prescribes it (DoHAC, n.d.-b).

What is TMS therapy?

The RANZCP, the college that trains and represents psychiatrists, describes rTMS in its position statement (last updated November 2018) as a pulsed magnetic field aimed at a small area of the brain’s outer layer, the cortex. The field creates small electrical currents that stimulate nerve cells in a region involved in mood regulation and depression. The magnetic pulses pass through the skull from a coil placed on your head (RANZCP, 2018).

  • It’s non-invasive. Nothing is implanted and there’s no surgery.
  • You stay awake. You don’t need an anaesthetic. Unlike ECT, rTMS does not deliberately induce a seizure, although a seizure is a rare possible complication.
  • It isn’t ECT. The RANZCP treats rTMS and electroconvulsive therapy (ECT) as distinct treatments with different side effects.
  • How it works isn’t fully understood. The exact mechanism is still being researched (RANZCP, 2018).

What is TMS used for in Australia?

In Australia, rTMS is mainly a treatment for major depressive disorder. The RANZCP says it suits a depressive episode that hasn’t responded to adequate trials of medication and/or psychological approaches. People with depression as part of bipolar disorder have shown similar response rates to people with unipolar depression, although few trials have focused on this group (RANZCP, 2018).

rTMS has also been studied for conditions such as schizophrenia, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD), but the RANZCP says the evidence there is less established than for depression. For under-18s there’s little safety and efficacy data, so the RANZCP limits its use to research or cases where other options are limited (RANZCP, 2018). Medicare’s rTMS items cover depression only, for people aged 18 or over (DoHAC, n.d.-b).

Who can get TMS through Medicare?

Medicare funds rTMS through four items in the Medicare Benefits Schedule (MBS). Wording in quotation marks is quoted from MBS Online, as at 7 November 2026 (DoHAC, n.d.-b).

MBS itemWhat it covers
14216Prescription and treatment mapping of an initial course, by a psychiatrist trained in rTMS
14217The initial course: “up to 35 services provided by, or on behalf of, a psychiatrist who has undertaken training in rTMS”
14219Prescription and treatment mapping of a retreatment course, by a psychiatrist trained in rTMS
14220The retreatment course: “up to 15 services provided by, or on behalf of, a psychiatrist who has undertaken training in rTMS”

Who is eligible for a first course

A first Medicare-funded course is for adults aged 18 or over with a major depressive episode who have not previously received TMS in a public or private setting. The criteria include adequate trials of at least two different classes of antidepressants, unless contraindicated, and psychological therapy where clinically appropriate. Your psychiatrist checks treatment history, medication doses, duration and adherence against the full item 14216 requirements (DoHAC, n.d.-b).

Referral

“Referral for item 14216 should be through a GP or a psychiatrist. Where there is an existing therapeutic relationship between the patient and the rTMS-trained psychiatrist, no additional referral is required” (DoHAC, n.d.-b).

Retreatment if depression comes back

Retreatment has additional conditions. These include relapse after remission following the initial Medicare-funded course, a satisfactory response assessed with a validated tool at least four months after that service, and the relevant age, diagnosis and prior-treatment requirements. Item 14220 also requires that the previous item 14217 service was not in the preceding four months and that item 14219 mapping has been completed. Your psychiatrist can explain whether you meet the retreatment requirements (DoHAC, n.d.-b).

Who gives the treatment, and where

  • The psychiatrist trained in rTMS must personally do the prescription and mapping. The treatment sessions can be given by that psychiatrist or by a trained health professional on their behalf, such as a nurse practitioner, practice nurse or allied health professional (DoHAC, n.d.-b).
  • MBS Online says most rTMS won’t need hospital treatment and can be given as an outpatient or in consultation rooms, though some people may need hospital treatment. Medicare benefits apply in both settings (DoHAC, n.d.-b).
  • For private health insurance to pay hospital benefits, the psychiatrist must certify in writing that hospital treatment is needed (DoHAC, n.d.-b).

What it costs

As at 7 November 2026, the MBS schedule fee is $214.45 for prescription and mapping (items 14216 and 14219) and $184.00 per treatment session (items 14217 and 14220) (DoHAC, n.d.-b). Ask the clinic what it charges, how much Medicare will pay back and what you’ll pay out of pocket before you start.

What does a course of TMS involve?

  • Frequency: rTMS is usually given several times a week, most commonly 5 times, for four to six weeks (RANZCP, 2018). The Medicare-funded first course allows up to 35 sessions (DoHAC, n.d.-b).
  • During a session: you’re awake and alert. The machine makes a loud clicking noise, so hearing protection such as ear plugs is advised (RANZCP, 2018).
  • Before you start: the psychiatrist discusses benefits, side effects and other options with you, and carefully assesses metal implants or devices such as pacemakers. The RANZCP says the results of rTMS can’t be guaranteed (RANZCP, 2018).
  • During the course: your response and any side effects should be checked regularly (RANZCP, 2018).
  • After the course: extra maintenance sessions to prevent relapse may help, but the RANZCP says the evidence for them is weaker than for a full course (RANZCP, 2018).

What does the research say about TMS?

Researchers usually report two outcomes. Response generally means depression scores dropped by at least half. Remission means scores fell below a cut-off on a standard depression rating scale (Vida et al., 2023).

  • The RANZCP’s position statement (last updated November 2018): there is a good evidence base for rTMS in major depressive disorder. Real-world studies of people with treatment-resistant depression put response rates at around 50% (RANZCP, 2018).
  • Compared with sham (placebo) treatment: a 2023 meta-analysis pooled double-blind, sham-controlled trials (19 for response, 9 for remission) of people whose depression hadn’t improved after two antidepressant treatments. People who had real rTMS added to their treatment were about 2.3 times as likely to respond, and about 2.8 times as likely to reach remission, as people who had sham rTMS. The authors noted that this effect was smaller than in earlier reviews (Vida et al., 2023).
  • A note of caution: a 2023 umbrella review looked at 29 systematic reviews of TMS for depression. It found that most of these reviews were of critically low quality and that results varied widely between settings. Its authors argued that TMS may not be as effective, and may be less well tolerated in some groups, than current evidence suggests (Brini et al., 2023).

These reviews include international studies; individual results and treatment suitability vary.

In short, research supports TMS as one option for some adults whose depression hasn’t responded to other treatment, but it doesn’t work for everyone and results vary.

Is TMS safe? What are the side effects?

The RANZCP says rTMS is well tolerated and safe when people are carefully screened and treatment stays within recommended safety limits (RANZCP, 2018).

  • Common side effects: scalp pain or discomfort, headache and twitching of the face muscles during stimulation. These are usually mild. In clinical trials, fewer than 2% of patients stopped treatment because of discomfort, and simple pain relief such as paracetamol may help (RANZCP, 2018).
  • Seizures: these are rare. The RANZCP says the risk appears to be extremely low with proper screening, and seems likely to be higher in people with existing neurological conditions or alcohol or substance use, and possibly during medication changes in the course (RANZCP, 2018). International expert safety guidelines also describe the seizure risk as low, even in people taking medicines that act on the brain, with standard stimulation settings (Rossi et al., 2021).
  • Mania or hypomania: rare, and most common in people with bipolar disorder (RANZCP, 2018).
  • Pregnancy: there is little safety data, so this needs a careful individual assessment (RANZCP, 2018).

How does psychology fit alongside TMS?

TMS isn’t an either/or choice with psychological therapy. The RANZCP says rTMS can be given in combination with psychological therapies or medication, depending on the person’s needs (RANZCP, 2018). Medicare’s criteria for a first course also include having “undertaken psychological therapy, if clinically appropriate” (DoHAC, n.d.-b).

Psychological therapy is itself an evidence-based treatment for depression. A 2023 meta-analysis of 409 trials with 52,702 patients found that cognitive behaviour therapy (CBT) had moderate to large effects compared with control conditions such as usual care or a waitlist. In the short term it worked about as well as antidepressant medication, and the combination of therapy and medication was more effective than medication alone (Cuijpers et al., 2023). This meta-analysis included international studies.

A psychologist can work with you on the thoughts, habits and situations that keep low mood going, and on a plan for noticing early warning signs. Read more on our depression treatment page and our CBT page. If you’re not sure who does what, see psychologist vs psychiatrist vs counsellor. Psychologists don’t prescribe TMS: in Australia it’s prescribed by a psychiatrist, who is a medical doctor, with training in rTMS (RANZCP, 2018).

Talk to your GP or psychiatrist about whether TMS suits you; psychology can continue alongside it.

How The Talk Shop can help

The Talk Shop doesn’t provide TMS. Referral for Medicare-funded TMS comes from a GP or a psychiatrist (DoHAC, n.d.-b). What we do offer is psychological therapy for depression with our team of psychologists.

  • In person, by video or by phone: see us in person at one of our four Melbourne clinics. Telehealth by video or phone is also available anywhere in Australia.
  • Private appointment availability: same-week appointments may be available, depending on clinician, location and suitability. Contact us for current availability.
  • No GP referral needed for private sessions. Medicare rebates under Better Access require an eligible referral and service. GP referrals are generally made under a Mental Health Treatment Plan by your usual GP or a GP at your MyMedicare practice; eligible psychiatrist and paediatrician referral pathways also exist. A plan is not itself a referral. Eligible patients can claim up to 10 individual services per calendar year, subject to referral and item requirements (DoHAC, n.d.-a). Ask us to confirm eligibility and out-of-pocket costs. See our prices and funding options.
  • Alongside your doctors: if you’re having TMS or other medical treatment, let your psychiatrist and psychologist know about each other’s care.

New to therapy? Here’s what to expect in your first psychology session.

Need support now? If you’re in immediate danger, call 000. For 24/7 crisis support, call Lifeline on 13 11 14 or the Suicide Call Back Service on 1300 659 467. We’re not a crisis service.

Frequently asked questions

Is TMS therapy covered by Medicare?
Yes, for some adults. MBS items 14216 and 14217 cover a first course of up to 35 rTMS sessions for people aged 18 or over who haven’t had TMS before and have a major depressive episode that hasn’t improved after adequate trials of at least 2 different classes of antidepressants, unless contraindicated. Psychological therapy should also have been tried, if clinically appropriate. An rTMS-trained psychiatrist must prescribe it (DoHAC, n.d.-b).

Do I need a referral for TMS?
For Medicare-funded TMS, MBS Online says referral should be through a GP or a psychiatrist. If you already see the rTMS-trained psychiatrist, no additional referral is required (DoHAC, n.d.-b).

Does TMS hurt?
It can be uncomfortable. Common side effects are scalp pain or discomfort, headache and facial twitching during stimulation, which are usually mild. You’re awake and don’t need an anaesthetic. Seizures are rare (RANZCP, 2018).

How long does a course of TMS take?
Sessions are usually given several times a week, most often 5 times, for four to six weeks (RANZCP, 2018). A Medicare-funded first course allows up to 35 sessions (DoHAC, n.d.-b).

Can I keep seeing a psychologist while I have TMS?
Yes. The RANZCP says rTMS can be combined with psychological therapies or medication (RANZCP, 2018). Talk to your GP or psychiatrist about whether TMS suits you; psychology can continue alongside it.

Does The Talk Shop offer TMS?
No. The Talk Shop doesn’t provide TMS. Referral for Medicare-funded TMS comes from a GP or a psychiatrist (DoHAC, n.d.-b). Our psychologists provide psychological therapy for depression in person at our four Melbourne clinics, by video or by phone.

Information current as at November 2026. Fees, rules and evidence change, so check the linked official sources.

References

Brini, S., Brudasca, N. I., Hodkinson, A., Kaluzinska, K., Wach, A., Storman, D., Prokop-Dorner, A., Jemioło, P., & Bala, M. M. (2023). Efficacy and safety of transcranial magnetic stimulation for treating major depressive disorder: An umbrella review and re-analysis of published meta-analyses of randomised controlled trials. Clinical Psychology Review, 100, Article 102236. https://doi.org/10.1016/j.cpr.2022.102236

Cuijpers, P., Miguel, C., Harrer, M., Plessen, C. Y., Ciharova, M., Ebert, D., & Karyotaki, E. (2023). Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: A comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry, 22(1), 105–115. https://doi.org/10.1002/wps.21069

Department of Health and Aged Care [now Department of Health, Disability and Ageing]. (n.d.-a). Note MN.6.3: Referral requirements for Better Access treatment services. Medicare Benefits Schedule. Retrieved November 7, 2026, from https://www9.health.gov.au/mbs/fullDisplay.cfm?type=note&q=MN.6.3&qt=noteID

Department of Health and Aged Care [now Department of Health, Disability and Ageing]. (n.d.-b). Note TN.1.28: Repetitive transcranial magnetic stimulation items 14216, 14217, 14219 and 14220. Medicare Benefits Schedule. Retrieved November 7, 2026, from https://www9.health.gov.au/mbs/fullDisplay.cfm?type=note&q=TN.1.28&qt=noteID

Rossi, S., Antal, A., Bestmann, S., Bikson, M., Brewer, C., Brockmöller, J., Carpenter, L. L., Cincotta, M., Chen, R., Daskalakis, J. D., Di Lazzaro, V., Fox, M. D., George, M. S., Gilbert, D., Kimiskidis, V. K., Koch, G., Ilmoniemi, R. J., Lefaucheur, J. P., Leocani, L., . . . Hallett, M. (2021). Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert guidelines. Clinical Neurophysiology, 132(1), 269–306. https://doi.org/10.1016/j.clinph.2020.10.003

Royal Australian and New Zealand College of Psychiatrists. (2018). Repetitive transcranial magnetic stimulation (Position Statement No. 79; last updated November 2018). https://www.ranzcp.org/clinical-guidelines-publications/clinical-guidelines-publications-library/repetitive-transcranial-magnetic-stimulation

Vida, R. G., Sághy, E., Bella, R., Kovács, S., Erdősi, D., Józwiak-Hagymásy, J., Zemplényi, A., Tényi, T., Osváth, P., & Voros, V. (2023). Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: Meta-analysis of randomized sham-controlled trials. BMC Psychiatry, 23(1), Article 545. https://doi.org/10.1186/s12888-023-05033-y

Talk to a psychologist this week

Same-week appointments, no waitlist for private or funded sessions. No GP referral is needed for private sessions. Low-cost sessions from $50 (25-minute telehealth session with a provisional psychologist).

Same-week appointments subject to availability. We are not a crisis service: if you or someone else is in danger, call 000. For 24/7 support, call Lifeline on 13 11 14.